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Although prostate cancer is common in the western world and is associated with favorable overall
survival, neuroendocrine prostate cancer is difﬁcult to detect and is known to aggressively metastasize
throughout the body. This subset of disease thus has a poor prognosis, and early detection and treatment
of neuroendocrine prostate cancer may increase overall survival. We present a case of a now deceased 63
year old male with extensive epicardial, respiratory, hepato-bilary, adrenal, genitourinary, and osseous
tissue metastasis.
 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The overwhelming majority of prostate cancers (PCa) are
adenocarcinomas, most of which are low-risk cases with excellent
long-term survival rates. In contrast, neuroendocrine differentiated
(NED) prostate adenocarcinoma is rare and has poor overall
survival.1 Here, we report a case of a man presenting with advanced
NED with diffuse metastasis to the viscera, including the heart,
lung, liver, adrenal gland, and thoracic-lumbar spine.Case presentation
In October 2014, a 63-year old Caucasian male with a past
medical history notable for benign prostatic hypertrophy status
post transurethral resection of the prostate presented to our
outpatient clinic complaining of acute urinary retention. A Foley
catheter was placed to relieve his obstruction and bladder disten-
tion. The digital rectal exam (DRE) was deferred to a later time.ocrine; NED, neuroendocrine
oendocrine; ADT, androgen
anklin Avenue, Garden City,
516 535 1905.
Inc. This is an open access article uThe patient returned to ofﬁce a month later with lab results that
showed an elevated PSA of 5.5 ng/mL and a sonogram report that
was notable for an enlarged prostate as well as multiple hepatic
masses suggestive of hepatocellular carcinoma or metastatic
disease. On DRE, the prostate was non-tender, enlarged, ﬁrm, and
irregular. A prostate biopsy andMRI were obtained aweek later and
the patient was instructed to follow-up for results. However, 2 days
prior to follow-up the patient presented to the Emergency
Department complaining of progressively worsening back pain
over the past 3 weeks. Review of symptoms showed a 10 lb weight
loss over the past 6 weeks, anorexia, fever, constipation, and
dyspnea. Lab results showed WBC 15 K/mL, hemoglobin 9 g/dL,
hematocrit 27.1%, creatinine 1.7 mg/dL, alkaline phosphatase
833 U/L, calcium 12.6 mg/dL, and PSA 6.5 ng/mL. The patient was
admitted and treated for lower back pain, incontinence, and
metastatic disease. MRI studies demonstrated diffuse hepatic
metastasis and distal obstruction of the left ureterovesical junction,
with further widespread bony metastasis to the thoracic and lum-
bar spine, as well as a recent T-12 fracture (Fig. 1). Radiation
oncology was consulted at this time to provide palliative radio-
therapy to metastatic sites in his spine.
Later that same day, the patient was reported to have hematuria
and urology was consulted to perform continuous bladder irriga-
tion. Around the time of urinary catheter insertion on the third day
of hospitalization, the patient went into asystole and subsequently
expired. The patient’s family requested an autopsy.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Microscopic examination of a single epicardial metastasis invading into
myocardium.
Figure 2. Coronal section of the liver showing diffuse metastasis and hepatomegaly.
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Upon microscopic examination of the prostate, the cancer was
rated a Gleason score of 10 (5 þ 5) in 11 of 12 cores with mixed
conventional acinar adenocarcinoma and small cell NE carcinoma.
Local invasion of the seminal vesicle and periprostatic fat was
observed with extension into the serosal and subserosal surfaces of
the bladder. Metastatic prostatic adenocarcinomawas identiﬁed on
the epicardial surface of the heart invading into the myocardium
(Fig. 1). Immunohistochemical studies of the cancer cells were
diffusely positive for synaptophysin and chromogranin. Immunos-
tains were also positive for PAP, but negative for PSA, CK7, CK20,
p63, and TTF1.
Gross ﬁndings on the autopsy were widespread, involving
cardiac, respiratory, hepato-biliary, adrenal, genitourinary and
osseous tissue. Cardiac ﬁndings included a singular ﬁrm, tan nodule
on the posterior epicardial surface. Respiratory ﬁndings included
multiple subpleural nodules seen in bilateral, upper and lower
lobes. Liver parenchyma and external surface had areas of pallor
and multiple well circumscribed, metastatic nodules resulting in
hepatomegaly (Fig. 2). The bladder was thin and distended with
multiple solid irregular nodules distributed diffusely on the serosal
surface. A 160 g blood clot was noted internally on section. The
bladder mucosa was hemorrhagic with a polypoid mass that
extended up from the prostate into the bladder. There were
multiple metastatic nodules that invaded into the perineum
between the rectum and the bladder. The thoracic-lumbar spine
was found to have multiple areas metastasis with cortical
destruction and evidence of a mild T12 fracture (Fig. 3).Figure 3. Metastatic lesions of the thoracolumbar vertebra and disc space on gross
examination. There was evidence of a mild T12 fracture.Discussion
Neuroendocrine (NE) prostate carcinomas aggressively metas-
tasize to the lymphatics, bone, bladder, vocal chords, and drastically
reduce cancer speciﬁc survival.1,2 The epicardial metastasis of PCa
as described herein is a rare occurrence that has scarcely been
cataloged in clinical practice.
NE tumorigenesis does not result from the proliferation of
prostate NE cells. Rather, this carcinoma arises from the differen-
tiation of prostate adenocarcinoma into “NE-like” cells.1 These cells
do not express androgen receptors or PSA, elucidating why NE PCa
is not responsive to aggressive androgen deprivation therapy (ADT)
and is not associated with an elevated PSA.1 In addition, severalseries have suggested that ADT, the standard treatment in menwith
advanced PCa, may induce neuroendocrine differentiation.3 The
vast majority of prostate cancers are adenocarcinomas, which rely
on androgens to grow and proliferate. Nevertheless, nearly all
tumors treated with hormones eventually develop resistance to
androgen deprivation and can grow even in the absence of these
hormones. Given that our patient had not received any hormonal
treatment prior to diagnosis, his NE tumorigenesis likely developed
spontaneously.
Since men rarely undergo prostate biopsy following metastasis,
NE prostate cancers may be misclassiﬁed as simply metastatic-
castration-resistant cancer, and so its detection rate is likely
substantially lower than its incidence rate. This confusion is only
further exacerbated by the similar aggressive nature of both of
these subsets of disease. Since PCa with neuroendocrine differen-
tiation does not present with high serum PSA, a high degree of
clinical suspicion must be utilized to detect and eradicate this dis-
ease in its early stages. Metastasis-induced pericardial effusion is
one of the ﬁrst clinical signs of a cardiac malignant tumor and can
be assessed for in patient with no history of neoplasms. Cross-
sectional imaging such as CT or MRI may be utilized in place of
serum biomarkers.4 Proper immunostaining is always recom-
mended for young patients with high grade tumors in order to
investigate the possibility of NED. In regards to our patient, a
physical examination must include a DRE to rule out suspicion of
PCa.
D.J. Habibian et al. / Urology Case Reports 8 (2016) 49e51 51Currently, no consensus has been reached regarding the optimal
management of NED PCa. However, physicians often adopt a
multimodal approach, utilizing chemotherapy systemically and
radiation for local control or palliation.Conﬂicts of interest
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